SARA REGINO: Open Payments
NPI 1497389050 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,334 in 94 payments from 11 companies in 2025. Trend: 2023 $2,254 · 2024 $6,181 · 2025 $7,334
Speaker / faculty: $4,295Food & beverage: $2,162Travel & lodging: $877
| Company | Payments | Amount |
|---|---|---|
| EVOKE PHARMA, INC. | 13 | $5,481 |
| ABBVIE INC. | 29 | $744 |
| QOL Medical, LLC | 10 | $380 |
| Aimmune Therapeutics, Inc. | 18 | $275 |
| Ardelyx, Inc. | 12 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
| Janssen Biotech, Inc. | 2 | $54 |
| Novo Nordisk Inc | 2 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| Medtronic, Inc. | 1 | $28 |
Products named: GIMOTI, Sucraid, SKYRIZI, CREON, IBSRELA, VOWST, RINVOQ, ZENPEP.
Industry payments across FL — which companies pay providers there.
